Palau vs Russia: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Palau
95.0%
in 2025
Russia
95.0%
in 2025
Palau rank
37th
Russia rank
37th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Palau
- Russia
How they compare
Palau currently reports 95.0% against 95.0% in Russia, a difference of 0.0%.
The two have swapped places 1 time across 18 shared years of data; in 2008 it was Palau ahead.
Palau ranks 37th and Russia ranks 37th of 192 countries.
Across the 3 decades both report, Palau averaged higher in 2 and Russia in 1.
Head to head by decade
| Decade | Palau | Russia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 12.5% | 0.0% | 12.5% | Palau |
| 2010s | 81.2% | 27.1% | 54.1% | Palau |
| 2020s | 86.0% | 91.7% | 5.7% | Russia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Palau or Russia?
- Palau, at 95.0% against 95.0% in Russia as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Palau and Russia?
- 0.0%, with Palau ahead.
- How many years of comparable data are there for Palau and Russia?
- 18 years are reported by both, from 2008 to 2025.
- How do Palau and Russia rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Palau ranks 37th and Russia ranks 37th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.